×
For best experience we recommend to activate Javascript in your browser.
SAMD3 antibody (AA 62-197) (Biotin)
The Biotin-conjugated Rabbit Polyclonal anti-SAMD3 antibody (ABIN7170742) specifically detects SAMD3 in ELISA.
The antibody is reactive with Human samples.
Catalog No. ABIN7170742
$394.68
Plus shipping costs $50.00
50 μg ABIN7357769
100 μg ABIN7170742
50 μg ABIN7357769
100 μg ABIN7170742
Delivery in 13 to 17 Business Days
Quick Overview for SAMD3 antibody (AA 62-197) (Biotin) (ABIN7170742)
Target
SAMD3
(Sterile alpha Motif Domain Containing 3 (SAMD3))
Reactivity
All reactivities for SAMD3 antibodies
Human
Host
All hosts for SAMD3 antibodies
Rabbit
Clonality
All clonalities for SAMD3 antibodies
Polyclonal
Conjugate
All conjugates for SAMD3 antibodies
This SAMD3 antibody is conjugated to Biotin
Application
All applications for SAMD3 antibodies
ELISA
Product Details anti-SAMD3 Antibody (Biotin)
(hide)
Binding Specificity
All epitopes for SAMD3 antibodies
AA 62-197
Purpose
SAMD3 Antibody, Biotin conjugated
Purification
Protein G purified
Purity
>95 %
Immunogen
Recombinant Human Sterile alpha motif domain-containing protein 3 protein (62-197AA)
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Preservative: 0.03 % Proclin 300 Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C,-80 °C
Storage Comment
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Target Details for SAMD3
(hide)
Target
SAMD3
(Sterile alpha Motif Domain Containing 3 (SAMD3))
Alternative Name
SAMD3
Background
SAM domain-containing protein 3 antibody, SAMD3 antibody, SAMD3_HUMAN antibody, Sterile alpha motif domain containing 3 antibody, Sterile alpha motif domain-containing protein 3 antibody
UniProt
Q8N6K7
Recently viewed
(hide)
Chat with us , powered by LiveChat